A Bispecific Monoclonal Antibody Targeting Psl and PcrV for Chronic Pseudomonas Aeruginosa Infection in Patients With Bronchiectasis: Results From a Randomized, Double-Blind Placebo-Controlled Trial (GREAT-2)

M.B. Long(University of Dundee), James D. Chalmers(University of Dundee), Maria G. Belvisi(Imperial College London), Robert Lord(University of Manchester), S. Caskey(University of Ulster), B.J.M. New(University of Dundee), Chandani Hennayake(University of Dundee), C. Addy(Cardiff and Vale University Health Board), Emma Johnson(University of North Carolina at Chapel Hill), Kateryna Viligorska(University of Dundee), A. Digiandomenico(AstraZeneca (United States)), Amy Gilmour(University of Dundee), Margaret Band(NHS Tayside), Greg S. Martin(University of California, Berkeley), Oriol Sibila(Hospital Clínic de Barcelona), Michael R. Loebinger(Royal Brompton Hospital), Charles Haworth(Papworth Hospital NHS Foundation Trust), Alicia Marín(Hospital Universitari Germans Trias i Pujol), Eva Polverino(Vall d'Hebron Institut de Recerca), Holly Lind(University of Dundee), Adam T. Hill, Michael M. Tunney(Queen's University Belfast), Eve Mcintosh(University of Dundee), J.L. Whitehouse(Heartlands Hospital), Montserrat Vendrell(Universitat de Girona), Wayne Brailsford(AstraZeneca (Netherlands)), Philip Mitchelmore(Royal Devon and Exeter Hospital), Lydia Finney(Imperial College London), Guillermo Suárez-Cuartín(Bellvitge University Hospital), Harshana Bandara(NHS Tayside), John D. Stobo(University of Dundee), Stefano Aliberti(Mylan (Switzerland)), Joyce Norwell, Zsofia Eke(University of Dundee), Rod Hughes(AstraZeneca (United Kingdom)), A. Timothy, R.B. Galloway(University of Dundee), Hollian Richardson(University of Dundee), Rebecca C Hull(University of Dundee), Katharine Cartwright(AstraZeneca (United Kingdom))
American Journal of Respiratory and Critical Care Medicine
May 1, 2025
Cited by 8


Related Papers